Area of research
Endocrinology, Diabetes and Metabolism · Surgery
Research interest
Research focused on Liraglutide and Gynecology, with related work in Type 2 diabetes, Semaglutide, Overweight. Notable publications include 'Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design', 'Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use', and 'Cardiovascular safety of liraglutide: Pooled analysis of Major adverse cardiovascular events across weight management and Type 2 Diabetes development programs'.
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use
Risk of Major Cardiovascular Events in Patients With Type 2 Diabetes With and Without Prior CV Events: Results From The LEADER Trial
Pas d’interaction entre le bénéfice cardiovasculaire procuré par le liraglutide dans l’étude LEADER et l’existence d’une insuffisance cardiaque
Risque d’événements cardiovasculaires majeurs chez les diabétiques de type 2 avec ou sans antécédents d’évènements cardiovasculaires : une analyse de l’étude LEADER
Cardiovascular safety of liraglutide: Pooled analysis of Major adverse cardiovascular events across weight management and Type 2 Diabetes development programs